[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:lung-large-cell-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Lung Large Cell Carcinoma",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05198830","Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:16:57.705506Z","2026-05-05T02:43:29.070820Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05049837","PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification",[],"2026-08-26T02:19:09.651016Z","2026-05-13T02:55:06.279915Z",[],[]]